Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review
- PMID: 21347644
- DOI: 10.1007/s12185-011-0791-1
Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review
Abstract
The epidemiology of primary immune thrombocytopenia (ITP) is not well-characterized in the general population. Most published studies, which have included relatively small numbers of ITP patients, have been conducted in England or Scandinavian countries. No epidemiologic data from Asian countries have been published. This study describes the epidemiology of ITP in a Japanese population. We analyzed the database registry of the Ministry of Health, Labour, and Welfare of Japan, and extracted newly diagnosed acute and chronic ITP patients with a platelet count of <100 × 10(9)/L. From 2004 to 2007, 7,774 cases of ITP were reported, giving an overall incidence of 2.16/100,000/year. The incidence differed greatly between males and females, being 1.72 and 2.58, respectively. The median age of the total affected population was 56 years old. In male patients, there was a striking preponderance of boys below 4 years and a very high peak among those aged 75-89 years. In female patients, the number of ITP patients appeared to show a trimodal distribution by age, with the first peak representing patients below 4 years, the second peak those aged 20-34 years, and the third peak those aged 50-89 years. In conclusion, the incidence of ITP in Japan is not markedly different from that of European countries studied to date. This population-based study reveals that, contrary to previously published studies, the maximum age-specific incidence is in the eighth decade.
Similar articles
-
Epidemiology and Clinical Manifestations of Immune Thrombocytopenia.Hamostaseologie. 2019 Aug;39(3):238-249. doi: 10.1055/s-0039-1683416. Epub 2019 Mar 13. Hamostaseologie. 2019. PMID: 30868551 Review.
-
Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis.J Med Econ. 2020 Feb;23(2):184-192. doi: 10.1080/13696998.2019.1669329. Epub 2019 Oct 9. J Med Econ. 2020. PMID: 31547724
-
Incidence of adult primary immune thrombocytopenia in England-An update.Eur J Haematol. 2022 Sep;109(3):238-249. doi: 10.1111/ejh.13803. Epub 2022 Jun 26. Eur J Haematol. 2022. PMID: 35670140
-
Atopic dermatitis and association of risk for primary immune thrombocytopenia and autoimmune diseases among children: A nationwide population-based cohort study.Medicine (Baltimore). 2016 Jul;95(29):e4226. doi: 10.1097/MD.0000000000004226. Medicine (Baltimore). 2016. PMID: 27442647 Free PMC article.
-
Immune Thrombocytopenia in Children: Consensus and Controversies.Indian J Pediatr. 2020 Feb;87(2):150-157. doi: 10.1007/s12098-019-03155-4. Epub 2020 Jan 11. Indian J Pediatr. 2020. PMID: 31927692 Review.
Cited by
-
Oral eltrombopag for up to three years is safe and well-tolerated in Japanese patients with previously treated chronic immune thrombocytopenia: an open-label, extension study.Int J Hematol. 2013 Sep;98(3):323-30. doi: 10.1007/s12185-013-1401-1. Epub 2013 Jul 30. Int J Hematol. 2013. PMID: 23896965 Clinical Trial.
-
Seasonal Association of Immune Thrombocytopenia in Adults.Balkan Med J. 2015 Oct;32(4):347-51. doi: 10.5152/balkanmedj.2015.151223. Epub 2015 Oct 1. Balkan Med J. 2015. PMID: 26740892 Free PMC article.
-
Immune thrombocytopenic purpura increased risk of subsequent pancreatitis: A Nationwide population cohort study.Sci Rep. 2019 Nov 15;9(1):16923. doi: 10.1038/s41598-019-53165-7. Sci Rep. 2019. PMID: 31729447 Free PMC article.
-
Eltrombopag versus romiplostim in treatment of adult patients with immune thrombocytopenia: A systematic review incorporating an indirect-comparison meta-analysis.PLoS One. 2018 Jun 1;13(6):e0198504. doi: 10.1371/journal.pone.0198504. eCollection 2018. PLoS One. 2018. PMID: 29856837 Free PMC article.
-
The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan.PLoS One. 2021 Aug 26;16(8):e0256379. doi: 10.1371/journal.pone.0256379. eCollection 2021. PLoS One. 2021. PMID: 34437567 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical